Introduction
Although the involvement of stress-activated signaling pathways in the development of diabetic complications is well known, recent studies imply that several cellular stress mechanisms converge, even in the genesis of type 2 diabetes, and are accountable for the insulin-secretory and insulin-action defects. There is increasing evidence in support of a role for ER stress in modulating insulin secretion and insulin sensitivity in vitro and in vivo [1, 2] . Under ER stress conditions, several prosurvival mechanisms are activated by UPR, which protects the cell by translational attenuation, induction of chaperone synthesis, and ER-associated protein degradation. When ER stress is not mitigated, and homeostasis is not restored, the UPR triggers apoptosis [3] . Although IR is the hallmark of type 2 diabetes, there is now a consensus that impaired glucose regulation cannot develop without insulin deficiency. It appears that type 2 diabetes develops on the basis of normal but "weak" b cells, unable to cope with excessive functional demands imposed by IR. This suggests that at least initially, the b cell dysfunction of type 2 diabetes could be more functional than structural. Asian Indians with mild dysglycemia have been shown recently to exhibit reduced b cell function, regardless of age, adiposity, insulin sensitivity, or family history [4] . With the consideration of this and the plausible b cell apoptosis in type 2 diabetes with prolonged hyperglycemia/ hyperlipidemia, the studying of ER stress mechanisms merits attention.
The interplay of UPR/ER stress with inflammation, glucose/ lipid metabolism, and energy-control pathways underlies chronic, metabolic diseases, including type 2 diabetes [5] [6] [7] . Whereas stress-signaling pathways have been well studied in preclinical models, there is an imperative need to study the interconnectivity of these signaling alterations in the clinical diabetes setting. With the use of systemic markers and PBMCs as a surrogate cell model, several of our studies demonstrated the increased proinflammation and oxidative stress in patients with type 2 diabetes and its complications [8] [9] [10] [11] [12] [13] [14] . We have also shown impairment of an "immunomiR" (miR-146a) that links proinflammation and IR in patients with type 2 diabetes [15] . Whereas accelerating interest in the role of ER in metabolic disease has been fueled by recent reports showing pathways that link ER to inflammation [5, 16] , there is lack of studies on these aspects in Asian Indians who are more insulin resistant and more prone to develop type 2 diabetes and cardiovascular diseases [17] . As there might be a tight interconnectivity and overlapping regulation between ER stress and inflammation, we planned to investigate the extent of ER stress in PBMCs in patients with T2DM compared with control subjects and to analyze their relationship with inflammatory markers and glycemic/lipid control. Furthermore, we wanted to check whether such stress signals show any association with impairment of an immunomiR (the upstream regulatory signal) in patients with type 2 diabetes.
MATERIALS AND METHODS

Subject recruitment
The study subjects were recruited randomly from the ongoing epidemiology cohorts and from Dr. Mohan's Diabetes Specialties Centre, a tertiary diabetes center in Chennai, South India. Study groups comprised of 1) subjects with NGT (n = 35) and 2) patients with T2DM (n = 35), based on World Health Organization criteria for the diagnosis of diabetes [18] . Institutional ethical committee approval was obtained for the study, informed consent was obtained from all of the study subjects, and the study was conducted as per the Declaration of Helsinki. Fasting blood samples were collected in EDTA tubes and were handled separately for biochemical and molecular investigations. A gene-expression pattern of ER stress and inflammation/oxidative stress markers was probed in all of the study subjects. Protein expression of ER stress markers, miR-146a levels, its gene targets (IRAK1 and TRAF6), and caspase-3 activity was studied in a subset of (n = 15 each) of subjects with NGT and patients with T2DM.
Anthropometric measurements
Height, weight, and blood pressure were measured by use of standardized methods. BMI was calculated as weight (kg)/height (m 2 ). IR was calculated by HOMA-IR with use of the following formula: fasting insulin (mIU/ml) 3 fasting glucose (mmol/l)/22.5.
Biochemical parameters
Biochemical analyses were done on an Hitachi 912 autoanalyzer (Mannheim, Germany) by use of kits supplied by Roche Diagnostics (Mannheim, Germany). Fasting plasma glucose (glucose oxidase-peroxidase method), serum cholesterol (cholesterol oxidase-PAP method), serum triglycerides (triglycerides-PAP method), and HDL cholesterol (direct methodpolyethylene glycol-pretreated enzymes) were measured. LDL cholesterol was calculated by use of the Friedewald formula. Glycated hemoglobin (HbA1c) was estimated by high-pressure liquid chromatography by use of the Variant machine (Bio-Rad Laboratories, Hercules, CA, USA).
PBMC isolation
Freshly collected peripheral blood was carefully layered on histopaque gradient (1077) and centrifuged at 1600 rpm (500 g) for 30 min. The buffycoat interface, representing .90% lymphocytes, was aspirated and washed 3 times in PBS (with pH 7.4) and aliquoted for various experiments.
RNA isolation and real-time PCR
Total RNA from cells was isolated as described previously [15] . The RNA quality and concentration of total RNA were measured by use of nanodrop. RNA (1 mg) was converted to cDNA by use of 100 units RT enzyme, 40 LNA = locked nucleic acid, miR-146a = microRNA 146a, miRNA = microRNA, NGT = normal glucose tolerance, p22 phox = NADPH oxidase, PAP = phenol plus aminophenazone, PBMC = peripheral blood mononuclear cells, PERK = protein kinase R-like endoplasmic reticulum kinase, pNA = p-nitroanilide, snRNA = small nuclear RNA, SOCS3 = suppressor of cytokine signaling 3, SUMO = small ubiquitin modifier, T2DM = type 2 diabetes mellitus, TRAF6 = TNFR-associated factor 6, TRPC-6 = transient receptor potential channel 6, TXNIP = thioredoxin-interacting protein, UPR = unfolded protein response, XBP-1s = X box-binding protein 1 spliced, XBP-1u = X box-binding protein 1 unspliced sonicated and incubated for 1 h in ice and centrifuged at 16,000 g for 5 min at 4°C. The supernatant collected was quantified for protein by the Bradford method. Proteins (15 mg) were resolved on a 10% SDS-PAGE and transferred to polyvinylidine fluoride membranes. After 1 h blocking in 5% BSA and incubation with the appropriate primary antibodies and HRP-conjugated secondary antibodies, detection was performed by use of an ECL kit (GE Healthcare, Pittsburgh, PA, USA). b-Actin was used as an internal control. Mean densitometry data from independent experiments were normalized to control by use of ImageJ software and represented as the ratio of test protein and b-actin.
miR-146a expression and quantitative real-time PCR
First-strand cDNA was synthesized from 10 ng of the total RNA by use of a first-strand cDNA synthesis kit and miRNA-specific RT primer sets for target miRNA (hsa-miR-146a) and endogenous control U6 snRNA (hsa; Exiqon, Woburn, MA, USA). cDNA synthesis was carried at 50°C for 30 min and 85°C for 5 min. cDNA synthesis for the analysis of target genes (mRNA) was performed with 40 units RT enzyme, 40 mM Oligo (d)T 18 primer (New England Biolabs), 103 RT buffer, and 20 U RNase inhibitor (Amersham Biosciences), and 2.5 mM each dNTPS and primers of specific genes was incubated at 42°C for 1 h and heat inactivation of enzyme done at 85°C for 10 min. Quantitative real-time PCR was performed by use of the mercury LNA miRNA PCR system and SYBR Green master mix and with LNA-based primer sets for target miRNAs (hsa-miR-146a) and U6 snRNA (Exiqon). cDNA was diluted 1:10 with nuclease-free water, as per the manufacturer's instruction, and 4 ml each cDNA was used for quantitative real-time PCR in an ABI-7000 machine (Applied Biosystems) with appropriate cycle conditions. The expression level of miRNA was determined by use of 2 2DDCt and normalized to U6 snRNA. For real-time measurement of mRNAs, SYBR Green JumpStart ReadyMix (Sigma-Aldrich, St. Louis, MO, USA) was used for expression level of b-actin and respective target genes. The expression level of mRNA was determined by use of 2 2DDCt and normalized to b-actin.
Caspase-3 activity assay
Caspase-3 activity was determined by colorimetric assay by use of the caspasespecific, peptide-containing amino acid sequence Asp-Glu-Val-Asp that is conjugated to the color reporter molecule pNA (R&D Systems, Minneapolis, MN, USA). The cleavage of the peptide by the caspases releases the chromophore pNA, which is quantified spectrophotometrically at 405 nm. Cells harvested after treatment were lysed, and 10 mg protein was aliquoted from each sample into a 96 well plate. DTT (0.5 ml) was added to all of the wells, followed by addition of 50 ml 23 reaction buffer and 3.5 ml Caspase-3 colorimetric substrate. The plate was incubated at 37°C for 1 h and read at 405 nm by use of a microplate reader. Caspase-3 activity was expressed as mean 6 SE of OD.
Statistical analysis
All analyses were done by use of Windows-based Statistical Package for Social Sciences (SPSS, Version 16.0; Chicago, IL, USA). Data were expressed either as means 6 SD or means 6 SE. Comparisons between groups were performed by use of unpaired Student's t-test. Pearson correlation analysis was carried out to determine the relation of gene-expression signatures with other risk variables. Logistic regression analysis was used to determine the association of independent molecular signatures. P , 0.05 was considered statistically significant. Table 2 presents the clinical and biochemical characteristics of the study subjects. There were no significant differences in age and BMI between the study groups. Fasting plasma glucose (P = 0.014), glycated hemoglobin (HbA1c; P = 0.001), HOMA-IR (P = 0.002), total cholesterol (P = 0.005), serum triglycerides (P = 0.013), and LDL cholesterol (P = 0.011) were significantly higher in patients with T2DM compared with subjects with NGT. HDL cholesterol (P = 0.024) was significantly lower in patients with type 2 diabetes compared with subjects with NGT. Transcriptional analysis revealed that the gene expression of ER stress markers (GRP-78, XBP-1u, XBP-1s, PERK, IRE1a, ATF6, and CHOP) was elevated significantly in PBMCs from T2DM compared with control subjects (Fig. 1) . The mRNA expression of both the proinflammatory cytokines (TNF-a and IL-6) and oxidative stress markers (p22 phox , TXNIP, and TRPC-6) was also increased in PBMCs from patients with T2DM compared with control subjects (Fig. 2) . Interestingly, the mRNA expression of SOCS3 was seen reduced in PBMCs from T2DM compared with NGT (Fig. 2) . Table 3 illustrates the Pearson correlation analysis of ER stress genes with other clinical and biochemical/molecular variables in the study. Interestingly, mRNA expression of most of the ER stress markers from PBMCs significantly and positively correlated with poor glycemic control, dyslipidemia, IR, and inflammatory and oxidative stress markers (Table 3) . Logistic regression was performed by use of diabetes as the dependent variable and the ER stress markers as the independent variable ( Table 4) and CHOP (b, 1.03, P = 0.042) showed significant association with type 2 diabetes even after adjusting for age. However, this statistical significance was lost when the data are adjusted for TNF-a and IL-6. This implies a tight signaling cross-talk and interconnectivity between proinflammation and ER stress in type 2 diabetes. Consistent with the mRNA results, there was also an augmented protein expression of ER stress markers (GRP-78, XBP-1, PERK, IRE1a, and CHOP) in PBMCs from T2DM compared with NGT (Fig. 3) . As our earlier studies revealed a link between impaired miR-146a and proinflammation in type 2 diabetes [15] , we also probed the expression levels of miR-146 in this study. The miR-146a expression levels were decreased significantly (P , 0.001) in patients with type 2 diabetes compared with NGT (Fig. 4A) . We next examined the expression of 2 confirmed gene targets of miR-146a, viz., IRAK1 and TRAF6, and found both of them increased significantly in T2DM compared with NGT (Fig. 4B) . As caspase-3 activation is an early marker of apoptosis, we also estimated the chronic burden of ER stress and inflammation as a function of caspase-3 activity. Caspase-3 activity was also increased significantly in PBMCs from T2DM compared with NGT (Fig. 4C) . Interestingly, the miR-146a levels were negatively correlated to fasting plasma glucose, HBA1c, IR, triglycerides, as well as proinflammatory/oxidative gene markers and caspase-3 activity ( Table 5 ).
RESULTS
23.9 6 2 24.6 6 2 0.196 FPG, mg/dl 77 6 15 157 6 79 0.014 HbA1c, % 5.5 6 0.4 7.8 6 1.5 0.001 HOMA-IR 1.7 6 0.67 5.43 6 2.71 0.002 Total cholesterol, mg/dl 140 6 37 172 6 38 0.005 Serum triglycerides, mg/dl 120 6 46 158 6 79 0.013 HDL cholesterol, mg/dl 41 6 7.9 37 6 5.2 0.024 LDL cholesterol, mg/dl 108 6 31 122 6 34 0.011 Values are means 6 SD.
DISCUSSION
Our study presents the following clinically relevant findings. 1) Different arms of the ER stress markers (both at the gene and protein levels) were increased in PBMCs from patients with type 2 diabetes and correlate positively with glycemic and lipid levels, IR, and inflammatory and oxidative stress markers. 2) For the first-time, we have shown interconnectivity between decreased miR-146a levels and ER stress/proinflammation in patients with type 2 diabetes. 3) Our study also demonstrates ER stress susceptible, proinflammatory, and proapoptotic phenotypes of PBMCs in patients with type 2 diabetes, as is evident from increased caspase-3 activity and TRPC-6 gene signatures, along with the other stress-signaling alterations.
Emerging data show that one of the central elements in the activation of inflammatory pathways is ER stress [5, 21] . This molecular pathway is shown to interfere with the function of the major insulin target tissues-hypothalamus, liver, adipose tissues, muscle, and the pancreatic b cells [22] . Particularly, secretory cells, such as pancreatic b cells and adipocytes, face the challenge of increasing protein synthesis, several folds during acute or chronic glucolipotoxic stresses. Monocytes have been shown vulnerable and functionally impaired under ER stress in patients with type 2 diabetes [23] . Sage et al. [24] , have also shown that compared with healthy controls, individuals with metabolic syndrome had elevated mRNA levels of genes indicative of ER stress. Consistent with the literature in that the IRE1a-XBP-1 pathway is an early trigger of UPR [5] , we saw transcriptional upregulation of IRE1a and XBP-1 (both XBP-1u and XBP-1s) in Figure 2 . Relative gene-expression (mean 6 SE) data of inflammatory/ oxidative stress markers, viz., TNF-a, IL-6, SOCS3, TXNIP, p22 phox , and TRPC-6. *P , 0.05 compared with NGT; **P , 0.01 compared with NGT. PBMCs from patients with type 2 diabetes. In a recent study, ER stress markers IRE1a, GRP-78, and XBP-1s were shown to be increased significantly in adipose tissue of obese, pregnant women and women with gestational diabetes mellitus [25] . As XBP-1s activity can be modulated by post-translational modifications, including SUMOylation [26] and acetylation/deacetylation [27] , the physiologic and pathologic relevance of these regulatory events in the context of metabolic diseases warrants further studies. Importantly, our study not only observed increased mRNA and protein levels of ER stress markers in PBMCs from patients with type 2 diabetes but also demonstrated the association of these signatures with proinflammatory markers, poor glycemic control, and IR. The expression of ER stress markers has been found to be increased significantly in human islet cells from type 2 diabetes subjects, as characterized by increased expression and nuclear translocation of CHOP [28] . Postmortem studies also reported a 30-60% decrease in b cell mass in type 2 diabetes [29] [30] [31] [32] as a result of increased apoptosis [29] . Working with MIN6 b cells, islets isolated from db/db mice, as well as pancreas sections of humans with type 2 diabetes, Laybutt et al. [33] have shown ER stress contributing to b cell apoptosis in type 2 diabetes. Interestingly, Asian Indians with mild dysglycemia (prediabetes) have been shown recently to exhibit reduced b cell function regardless of age, adiposity, insulin sensitivity, or family history [4] . Although we used PBMCs as a surrogate cell model, our study implies a role of increased ER stress and proapoptotic signaling that is reflective of slow b cell deterioration in the natural history of type 2 diabetes. In addition to the IRE1a-and PERK-dependent UPR apoptotic pathways, ER stress can initiate other proapoptotic events, including relocalization of BCL-2 family members, cleavage of ER-specific caspases, p53 activation, and disruption of cellular calcium homeostasis [34, 35] . CHOP could be an important player of ER stress-mediated b cell death and may promote the progression of type 2 diabetes [36] . CHOP is positively controlled by the PERK-ATF4 axis, and CHOP has been shown to promote the transcription of BCL-2-interacting mediator and the downregulation of BCL-2 expression, contributing to the induction of apoptosis [37] . In this context, the increased CHOP gene and the protein expression pattern seen in type 2 diabetes patients in our study are important observations. Increased TRPC-6 mRNA expression in PBMCs from patients with type 2 diabetes in our study implies a role for increased calcium levels in PBMC dysfunction and ER stress. Alterations in Ca 2+ homeostasis have been demonstrated in diabetes and associated complications [38, 39] and are linked to ER stress. Loss of Ca 2+ homeostasis as a result of improper TRPC activation could lead to ER stress responses and even apoptosis [40] . Although it has been known that activation of the CHOP pathway of the UPR can cause apoptosis, the molecular mechanisms linking CHOP to death execution pathways are poorly understood. Our results here show that apoptosis might be executed by the activation of TRPC-6 and subsequent increase in cytosolic Ca 2+ load and increased activation of caspase-3 in PBMCs from patients with type 2 diabetes.
The increased TNF-a and IL-6 gene-expression patterns in T2DM observed in our study imply that these proinflammatory signals are important components in the pathogenesis of type 2 diabetes. We have also observed a decrease in the SOCS3 gene-expression levels in T2DM compared with NGT, which is in accordance with our earlier study [13] . The physiologic role of the SOCS proteins is most likely to prevent uncontrolled cytokine signaling in the cell by negative feedback. However, this mechanism seems to be compromised in glucoseintolerant subjects, as they exhibit low levels of SOCS3, despite increased transcription of TNF-a and IL-6. It is clear from in vitro and in vivo studies that chronic and even acute hyperglycemia can promote a significant increase in circulating biomarkers of inflammation, including IL-6 and TNF-a, which play a role in altering metabolic homeostasis. Activated macrophages that produce proinflammatory cytokines, such as TNF-a, IL-1b, and IL-6, are thought to contribute to IR in muscle and adipose tissues [17, 41, 42] . Interestingly in our study, proinflammation seen in patients with type 2 diabetes is linked to ER stress as well as miRNA regulation. We showed earlier impaired miR-146a levels to be linked to proinflammation and IR in type 2 diabetes [15] . miR-146a was found to be inducible upon stimulation with LPS in a NF-kB-dependent manner and to target the TRAF6 and IRAK1 genes [43] . In our study, increased ER stress markers in patients with type 2 diabetes were negatively correlated to miR-146a levels and positively correlated to miRNA target genes and proinflammatory markers. A few ER stress-inducible miRNAs have been identified and shown to hinder translation of various secretory pathway proteins [44, 45] , suggesting that miRNAs play integral roles in the UPR. Although further mechanistic studies are needed, our results suggest that the regulatory circuit of miR-146a regulation of inflammation has been lost in patients with type 2 diabetes, and it could have a causal link originating from increased ER stress. Whereas it has been recognized that inflammation plays a central role in type 2 diabetes, our results raise the possibility that ER stress is at the intersection of inflammation and metabolism. Over the past several years, this concept has been supported by genetic, experimental, and clinical evidence [1, 5, 19, 45] . A causal role for ATF5 and miR-17, mediated by TXNIP [46, 47] , has been demonstrated to link ER stress and inflammation, as these molecules are regulated by key regulators of the ER stress response, PERK and IRE1a. In the present study, we observed increased TXNIP gene expression in patients with type 2 diabetes, and it correlated well with the distal ER stress markers, such as CHOP. One of our earlier studies also delineated a role of increased TXNIP gene expression in type 2 diabetes, as TXNIP gene expression was positively associated with protein oxidation and gene-expression patterns of IL-6, TNF-a, and p22 phox in patients with type 2 diabetes [13] . Recently, Iwasaki et al. [16] have also described a molecular pathway linking ER to IL-6 production. With the use of DNA microarray and network analyses of macrophages, they showed compelling evidence that ATF4, which is involved in the ER stress response, played an essential role in IL-6 expression induced by various metabolic stresses, including ER stress.
Although we used PBMCs as a surrogate cell model, our study results of double burden of increased ER stress (with proapoptotic susceptibility) and proinflammation from patients with type 2 diabetes could be extrapolated to the underlying causes of b cell dysfunction. This is important, because of the recent genome-wide association studies, in which T2DM susceptibility genes are related to b cell dysfunction and loss of b cell mass [48] and the fact that b cell dysfunction has been evident even in youth-onset type 2 diabetes [49] and in subjects with prediabetes [4] . Because of the cross-sectional nature of our work, our study could not reveal any causal relationship between ER stress and type 2 diabetes, and for this, we need prospective follow-up studies. However, accumulating literature [50] [51] [52] gives directionality, in that ER stress targeting would be beneficial for prevention, as well as treatment strategies related to type 2 diabetes. As earlier initiation of insulin therapy in type 2 diabetes has been shown recently to facilitate "b cell rest," and preserve b cell mass and function [53] , further studies should delineate whether this could occur by reduction of ER stress.
To conclude, the interconnectivity between ER stress and proinflammation in our study, along with decreased miR-146a levels in patients with type 2 diabetes, is a new and unique observation of clinical significance. Whereas an antiinflammatory strategy still appears to be an important component, our study exposes an upstream role of ER stress and miRNA-mediated regulation at the intersection of inflammation and metabolism and points out ER stress pathway as an attractive target for immunometabolic diseases, including type 2 diabetes. 
